Skip to main content
Navigate Up
Sign In

Three-drug combination improves life for cystic fibrosis patients

“These results represent a major breakthrough in cystic fibrosis therapeutics, with the potential for improving health and possibly survival in all patients who carry the most common CFTR mutation,” Fernando Holguin of the University of Colorado, who was not involved in the studies, said in a commentary published in the New England Journal of Medicine. 
“Within 24 hours of taking the pill combination, patients were puffing less. Their sinuses were clearer. They had more energy,” Jennifer Taylor-Cousar of National Jewish Health, who led one of the study teams, told NBC News.